End-of-day quote
Shenzhen S.E.
06:00:00 2024-06-06 pm EDT
|
5-day change
|
1st Jan Change
|
27.28
CNY
|
+1.83%
|
|
+1.75%
|
-2.74%
|
Fiscal Period: December |
2022
|
2023
|
---|
Capitalization
1 |
2,789
|
2,911
|
Enterprise Value (EV)
1 |
2,211
|
2,520
|
P/E ratio
|
33.4
x
|
33.7
x
|
Yield
|
4.02%
|
1.93%
|
Capitalization / Revenue
|
4.03
x
|
3.71
x
|
EV / Revenue
|
3.2
x
|
3.21
x
|
EV / EBITDA
|
22.9
x
|
22
x
|
EV / FCF
|
53.6
x
|
-36.6
x
|
FCF Yield
|
1.87%
|
-2.73%
|
Price to Book
|
2.42
x
|
2.61
x
|
Nbr of stocks (in thousands)
|
103,805
|
103,805
|
Reference price
2 |
26.86
|
28.05
|
Announcement Date
|
4/21/23
|
4/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
592.5
|
620.7
|
634.2
|
679.7
|
691.6
|
785.2
|
EBITDA
1 |
122.7
|
129.4
|
136.5
|
129.5
|
96.47
|
114.8
|
EBIT
1 |
88.07
|
96.17
|
103.8
|
99.69
|
68.31
|
80.38
|
Operating Margin
|
14.86%
|
15.49%
|
16.36%
|
14.67%
|
9.88%
|
10.24%
|
Earnings before Tax (EBT)
1 |
115.1
|
109.8
|
124.5
|
119.1
|
81.86
|
101.3
|
Net income
1 |
86.25
|
82.59
|
98.74
|
101.7
|
67.8
|
86.31
|
Net margin
|
14.56%
|
13.31%
|
15.57%
|
14.97%
|
9.8%
|
10.99%
|
EPS
2 |
1.135
|
1.061
|
1.351
|
1.307
|
0.8039
|
0.8321
|
Free Cash Flow
1 |
-34.34
|
96.78
|
11.86
|
21.08
|
41.25
|
-68.83
|
FCF margin
|
-5.8%
|
15.59%
|
1.87%
|
3.1%
|
5.97%
|
-8.77%
|
FCF Conversion (EBITDA)
|
-
|
74.78%
|
8.68%
|
16.28%
|
42.76%
|
-
|
FCF Conversion (Net income)
|
-
|
117.18%
|
12.01%
|
20.72%
|
60.85%
|
-
|
Dividend per Share
2 |
0.7966
|
0.3854
|
0.5909
|
-
|
1.081
|
0.5405
|
Announcement Date
|
9/30/20
|
9/30/20
|
5/19/21
|
9/1/22
|
4/21/23
|
4/21/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
21.3
|
51.8
|
77.4
|
78.7
|
578
|
392
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-34.3
|
96.8
|
11.9
|
21.1
|
41.3
|
-68.8
|
ROE (net income / shareholders' equity)
|
24.7%
|
18.9%
|
19.6%
|
16.6%
|
7.55%
|
7.65%
|
ROA (Net income/ Total Assets)
|
7.22%
|
7.86%
|
8.12%
|
7.25%
|
3.75%
|
3.66%
|
Assets
1 |
1,195
|
1,051
|
1,216
|
1,403
|
1,807
|
2,357
|
Book Value Per Share
2 |
5.460
|
5.200
|
7.530
|
8.250
|
11.10
|
10.70
|
Cash Flow per Share
2 |
0.7000
|
0.6100
|
0.8100
|
0.8300
|
3.290
|
2.300
|
Capex
1 |
17
|
21.2
|
31.2
|
38.2
|
23.6
|
134
|
Capex / Sales
|
2.87%
|
3.42%
|
4.91%
|
5.62%
|
3.41%
|
17.07%
|
Announcement Date
|
9/30/20
|
9/30/20
|
5/19/21
|
9/1/22
|
4/21/23
|
4/21/24
|
|
1st Jan change
|
Capi.
|
---|
| -2.74% | 377M | | +45.82% | 765B | | +40.95% | 632B | | -6.16% | 354B | | +19.86% | 331B | | +9.32% | 299B | | +18.45% | 248B | | -0.78% | 219B | | +11.88% | 216B | | +5.90% | 164B |
Other Pharmaceuticals
|